Skip to main content

Table 2 Sensitivity and specificity for nine candidate genes in classifying prostate tumor vs normal

From: Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression

Gene

Sensitivity

Specificity

ASB2

0.631

0.914

ETNK2

0.797

0.943

KCNJ15

0.778

0.886

MEIS2

0.839

0.829

NRG1

0.619

0.971

NTN1

0.749

0.771

NUDT10

0.787

0.743

PDE4A

0.759

0.829

SRPX

0.73

0.714